Vendor Watch

Tex Peptides

ACTIVE

Last checked

October 5, 2026 (homepage loaded; product listings not reviewed).

Latest item

Sept. 1, 2026: FDA posted a warning letter dated Aug. 24, 2026 (Dallas, TX). FDA says the firm sells unapproved new drugs and that “research use only” labeling does not change that.

Public enforcement record

FDA warning letter dated August 24, 2026, posted September 1, 2026, citing sections 301(d) and 505(a) of the FD&C Act. These are FDA’s allegations; the firm was given 15 business days to respond.

Company response

None located. We did not search beyond the FDA page and the company homepage.

Timeline

2026-08-24FDA issues a warning letter to the firm (Dallas, TX).
2026-09-01FDA posts the letter. The firm has 15 business days from receipt to respond.

Current storefront and channel observations

2026-10-05Observed by us: the homepage loads. Which cited products remain listed was not checked.

Documented enforcement records

Product additions and removals

No product changes recorded.

Statements and replies

No statements located.

Stories

FDA FILEDOCUMENTED
FDA tells five peptide sellers “research use only” labels do not exempt their injectables

DOCUMENTED. FDA posted warning letters on Sept. 1, 2026 (dated Aug. 24) to five peptide sellers, stating that products sold as “research use only” are unapproved new drugs. The letters are FDA’s allegations; each firm was told to respond within 15 business days.

Observed 2026-09-01 · Published 2026-10-05

Community chatter

Kept separate from confirmed reporting. Not verified.

None recorded.

Updates and corrections

None. Request a correction.

Record note: This page is a dated record of public documents, observed website changes, company statements, and clearly labeled community discussion. It is updated as new information becomes available.